<DOC>
	<DOCNO>NCT00639600</DOCNO>
	<brief_summary>This research project support multicentric network collaborator whose goal ass efficacy transplant allogenic pancreas islet restore insulin secretion patient type 1 , insulin-dependent diabetes mellitus kidney transplantation improve metabolic control .</brief_summary>
	<brief_title>Transplantation Pancreatic Islets Patients With Type 1 Diabetes Mellitus Functional Kidney Graft</brief_title>
	<detailed_description>The main objective demonstrate beneficial effect islet allotransplantation patient type 1 diabetes endogenous insulin secretion , functional kidney graft . The objective evaluate condition efficacy islet cell transplantation , assess improvement quality life cost islet cell transplantation .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Type 1 diabetes mellitus Disease duration &gt; 5 year ketose antecedent Basal stimulate plasma C &lt; 0.2 ng/ml , &lt; 0.06 nmol/l ( glycemia must measure simultaneously_ 1.20 g/l 6.6 mM , stimulation glucagon IV 1 mg Measured à T0 T 6 min ) Established kidney graft ≥ 6 month Current creatinine clearance : ≥ 50 ml/min/1.73 m² Proteinuria &lt; 0.5 g/24h HbA1C &lt; 12 % Hemostasis problem Documented hepatic pathology Patient 18 65 yearold Women body weight 70 kg ( tolerance 2 kg inclusion day transplantation day ) BMI &gt; 26 Men body weight &gt; 75 kg ( tolerance 3 kg inclusion day transplantation day ) BMI &gt; 26 insuline need &gt; 0.7 U/kg/j 50 U/j Serious lifethreatening pathology untreated hyperlipidemia Hypersensitivity drug rapamycinealike Liver disease ( transaminases total bilirubin ≥ 3N ) Failure communicate cooperate investigator Exclusion criterion specific use Rapamycine Hypercholesterolemia ( &gt; 350mg/dl , 9,1 mmol/l ) control Hypertriglyceridemia ( &gt; 500 mg/dl , 5,6 mmol/l ) control Leukocytes &gt; 4500 /mm3 , neutrophils &gt; 2000/ mm3 , platelet &gt; 100000/ mm3 Any clinical biological pathology could interfere study Past present neoplasia ( exception non melanoma skin cancer ) Any hemostasis disorder need prolonged treatment anticoagulation drug . Lowdose aspirin permit . Pregnancy , lactation , pregnancy project absence efficient contraception Any medical psychosocial condition susceptible interfere study , drug abuse recent alcohol abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
</DOC>